Belgium
Tuberculosis profile
Population  2013 11 million
Estimates of TB burden * 2013 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 0.018 (0.018–0.019) 0.16 (0.16–0.17)
Mortality (HIV+TB only) <0.01 (<0.01–<0.01) 0.04 (0.02–0.05)
Prevalence  (includes HIV+TB) 1.3 (0.54–2.3) 11 (4.9–21)
Incidence  (includes HIV+TB) 1 (0.94–1.1) 9.1 (8.5–10)
Incidence (HIV+TB only) 0.04 (0.038–0.04) 0.36 (0.35–0.36)
Case detection, all forms (%) 90 (82–96)    
Estimates of MDR-TB burden * 2013   New   Retreatment
% of TB cases with MDR-TB 1.6 (0.69–3.1) 13 (5.5–25)
MDR-TB cases among notified pulmonary
TB cases
10 (4–19) 10 (4–19)
TB case notifications 2013 New ** Relapse
Pulmonary, bacteriologically confirmed 548    
Pulmonary, clinically diagnosed 77    
Extrapulmonary 281    
       
Total new and relapse 906    
Previously treated, excluding relapses 75    
Total cases notified 981    
Among 906 new and relapse cases:
59 (7%) cases aged under 15 years; male:female ratio: 1.8
Reported cases of RR-/MDR-TB 2013 New Retreatment Total **
Cases tested for RR-/MDR-TB 520 (95%) 48 (64%) 729
Laboratory-confirmed RR-/MDR-TB cases     15
Patients started on MDR-TB treatment     12
TB/HIV 2013 Number (%)
TB patients with known HIV status 492 (50)
HIV-positive TB patients 36 (7)
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT)    
HIV-positive TB patients on antiretroviral therapy (ART)    
HIV-positive people screened for TB    
HIV-positive people provided with IPT    
Treatment success rate (%)
New and relapse cases registered in 2012 77
Previously treated cases, excluding relapse, registered in 2012 72
HIV-positive TB cases, all types, registered in 2012 70
RR-/MDR-TB cases started on second-line treatment in 2011 75
XDR-TB cases started on second-line treatment in 2011 67
Laboratories 2013  
Is second-line drug susceptibility testing available? Yes, in country
Financing TB control 2014  
National TB programme budget (US$ millions)  
* Ranges represent uncertainty intervals
** Includes cases with unknown previous TB treatment history
***
(Rate per 100 000 population per year)
Mortality graph
   Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
   Prevalence

(Rate per 100 000 population per year)
Incidence graph
   Notified (new and relapse)   Incidence
   Incidence (HIV+TB only)

(Number of patients)
CPT ART graph
   HIV-positive TB patients
   on CPT   on ART

Treatment success rate (%)
tx success graph
   New   Retreatment
   New and relapse   Retreatment, excluding
relapse
   HIV-positive   RR-/MDR-TB   XDR-TB

 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 Generated: 2015-08-01 Data: www.who.int/tb/data